The De Ritis and Neutrophil-to-Lymphocyte Ratios May Aid in the Risk Assessment of Patients with Metastatic Renal Cell Carcinoma

PURPOSE: This study aimed to determine whether baseline blood inflammatory markers can predict progression-free survival (PFS) and overall survival (OS) in patients with metastatic renal cell carcinoma (mRCC). METHODS: The study included 158 patients with mRCC treated with first-line targeted therap...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Sung Han, Park, Eun Young, Joo, Jungnam, Chung, Jinsoo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6312581/
https://www.ncbi.nlm.nih.gov/pubmed/30662462
http://dx.doi.org/10.1155/2018/1953571

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6312581/
https://www.ncbi.nlm.nih.gov/pubmed/30662462
http://dx.doi.org/10.1155/2018/1953571

Ejemplares similares